LymphedemaV1, PubMed, Checkpoint, bibRecord, 004D88

[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].

Identifieur interne : 004D88 ( PubMed/Checkpoint ); précédent : 004D87; suivant : 004D89

[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].

Auteurs : C. Track [Autriche] ; D H Seewald ; J P Zoidl ; J. Hammer

Source :

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [ 0179-7158 ] ; 1994.

RBID : pubmed:8165518

Descripteurs français

KwdFr :
- Association thérapeutique, Curiethérapie, Dosimétrie en radiothérapie, Femelle, Humains, Radio-isotopes de l'iridium (usage thérapeutique), Taux de survie, Tumeurs du sein (), Tumeurs du sein (radiothérapie), Études de suivi.
MESH :
- radiothérapie : Tumeurs du sein.
- usage thérapeutique : Radio-isotopes de l'iridium.
- Association thérapeutique, Curiethérapie, Dosimétrie en radiothérapie, Femelle, Humains, Taux de survie, Tumeurs du sein, Études de suivi.

English descriptors

KwdEn :
- Brachytherapy, Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Breast Neoplasms (therapy), Combined Modality Therapy, Female, Follow-Up Studies, Humans, Iridium Radioisotopes (therapeutic use), Radiotherapy Dosage, Survival Rate.
MESH :
- chemical , therapeutic use : Iridium Radioisotopes.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- therapy : Breast Neoplasms.
- Brachytherapy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Radiotherapy Dosage, Survival Rate.

Abstract

In the breast conserving management of mammary cancer a high-dose-rate (HDR)-Iridium-192 source is used for interstitial boosting of the primary tumor site after external radiotherapy. We want to show the clinical results and side effects and to demonstrate the safe use of a HDR source.

PubMed: 8165518

Affiliations:

Autriche

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 005567
to stream PubMed, to step Curation: 005567

Links to Exploration step

pubmed:8165518

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].</title>
<author><name sortKey="Track, C" sort="Track, C" uniqKey="Track C" first="C" last="Track">C. Track</name>
<affiliation wicri:level="1"><nlm:affiliation>Abteilung für Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz, Osterreich.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Autriche</country>
<wicri:regionArea>Abteilung für Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz</wicri:regionArea>
<wicri:noRegion>Linz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Seewald, D H" sort="Seewald, D H" uniqKey="Seewald D" first="D H" last="Seewald">D H Seewald</name>
</author>
<author><name sortKey="Zoidl, J P" sort="Zoidl, J P" uniqKey="Zoidl J" first="J P" last="Zoidl">J P Zoidl</name>
</author>
<author><name sortKey="Hammer, J" sort="Hammer, J" uniqKey="Hammer J" first="J" last="Hammer">J. Hammer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:8165518</idno>
<idno type="pmid">8165518</idno>
<idno type="wicri:Area/PubMed/Corpus">005567</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005567</idno>
<idno type="wicri:Area/PubMed/Curation">005567</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005567</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005567</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005567</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].</title>
<author><name sortKey="Track, C" sort="Track, C" uniqKey="Track C" first="C" last="Track">C. Track</name>
<affiliation wicri:level="1"><nlm:affiliation>Abteilung für Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz, Osterreich.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Autriche</country>
<wicri:regionArea>Abteilung für Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz</wicri:regionArea>
<wicri:noRegion>Linz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Seewald, D H" sort="Seewald, D H" uniqKey="Seewald D" first="D H" last="Seewald">D H Seewald</name>
</author>
<author><name sortKey="Zoidl, J P" sort="Zoidl, J P" uniqKey="Zoidl J" first="J P" last="Zoidl">J P Zoidl</name>
</author>
<author><name sortKey="Hammer, J" sort="Hammer, J" uniqKey="Hammer J" first="J" last="Hammer">J. Hammer</name>
</author>
</analytic>
<series><title level="j">Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</title>
<idno type="ISSN">0179-7158</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brachytherapy</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Iridium Radioisotopes (therapeutic use)</term>
<term>Radiotherapy Dosage</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term>
<term>Curiethérapie</term>
<term>Dosimétrie en radiothérapie</term>
<term>Femelle</term>
<term>Humains</term>
<term>Radio-isotopes de l'iridium (usage thérapeutique)</term>
<term>Taux de survie</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Iridium Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Radio-isotopes de l'iridium</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Brachytherapy</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Radiotherapy Dosage</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term>
<term>Curiethérapie</term>
<term>Dosimétrie en radiothérapie</term>
<term>Femelle</term>
<term>Humains</term>
<term>Taux de survie</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In the breast conserving management of mammary cancer a high-dose-rate (HDR)-Iridium-192 source is used for interstitial boosting of the primary tumor site after external radiotherapy. We want to show the clinical results and side effects and to demonstrate the safe use of a HDR source.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8165518</PMID>
<DateCreated><Year>1994</Year>
<Month>05</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted><Year>1994</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0179-7158</ISSN>
<JournalIssue CitedMedium="Print"><Volume>170</Volume>
<Issue>4</Issue>
<PubDate><Year>1994</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</Title>
<ISOAbbreviation>Strahlenther Onkol</ISOAbbreviation>
</Journal>
<ArticleTitle>[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].</ArticleTitle>
<Pagination><MedlinePgn>213-7</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In the breast conserving management of mammary cancer a high-dose-rate (HDR)-Iridium-192 source is used for interstitial boosting of the primary tumor site after external radiotherapy. We want to show the clinical results and side effects and to demonstrate the safe use of a HDR source.</AbstractText>
<AbstractText Label="PATIENTS AND METHOD" NlmCategory="METHODS">From December 1984 until November 1988, 154 patients with breast cancer stage T1-2, N0-1 were treated by conservative surgery and radiation. A dose of 45 to 50 Gy was given to the whole breast by external radiotherapy, and the previous tumor area was boosted by an interstitial implant with Iridium-192 HDR. We applied 10 Gy in one or two fractions.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean follow-up period of survivors is 76 months (range 57 to 107 months). In 36 patients failures occurred: eight patients (5%) developed local recurrences, 31 patients (20%) had distant metastases, and 19 (12%) died with cancer. The Kaplan-Meier estimation for five year overall survival is 86.9%, for disease-specific survival 89.3%, for local control 95.8%, and for disease free survival 80.1%. The most frequent late effects were telangiectasia (11%), fibrotic masses in the previous tumor area (6.5%), and lymphedema of the arm (6.5%). No serious complications could be observed.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">With the HDR-Boost of 10 Gy in addition to external beam radiotherapy in the treatment of breast cancer we obtained good clinical results without serious side effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Track</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Abteilung für Radioonkologie, Krankenhaus der Barmherzigen Schwestern, Linz, Osterreich.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Seewald</LastName>
<ForeName>D H</ForeName>
<Initials>DH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zoidl</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hammer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Externe Bestrahlung und interstitielle HDR-Brachytherapie in der Behandlung des Mammakarzinoms.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Strahlenther Onkol</MedlineTA>
<NlmUniqueID>8603469</NlmUniqueID>
<ISSNLinking>0179-7158</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007496">Iridium Radioisotopes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001918" MajorTopicYN="Y">Brachytherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007496" MajorTopicYN="N">Iridium Radioisotopes</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>4</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">8165518</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Autriche</li>
</country>
</list>
<tree><noCountry><name sortKey="Hammer, J" sort="Hammer, J" uniqKey="Hammer J" first="J" last="Hammer">J. Hammer</name>
<name sortKey="Seewald, D H" sort="Seewald, D H" uniqKey="Seewald D" first="D H" last="Seewald">D H Seewald</name>
<name sortKey="Zoidl, J P" sort="Zoidl, J P" uniqKey="Zoidl J" first="J P" last="Zoidl">J P Zoidl</name>
</noCountry>
<country name="Autriche"><noRegion><name sortKey="Track, C" sort="Track, C" uniqKey="Track C" first="C" last="Track">C. Track</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D88 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004D88 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:8165518
   |texte=   [External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:8165518" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].

[External irradiation and interstitial HDR brachytherapy in the treatment of breast cancer].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki